UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis

Current Alzheimer research, 2018-01, Vol.15 (7), p.637-642

2018

Volltextzugriff (PDF)

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

Neurology, 2003-07, Vol.61 (2), p.199-205

2003

Volltextzugriff (PDF)

A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Neurobiology of disease, 2001-10, Vol.8 (5), p.890-899

2001

Volltextzugriff (PDF)

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin : implications for Alzheimer's disease

Journal of Neural Transmission, 2000-01, Vol.107 (2), p.203-231

2000

Volltextzugriff (PDF)

Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo

The American journal of pathology, 1998-04, Vol.152 (4), p.871-877

1998

Volltextzugriff (PDF)

Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

Journal of neurochemistry, 1998-05, Vol.70 (5), p.2212-2215

1998

Volltextzugriff (PDF)

Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model

Neurobiology of disease, 2000-08, Vol.7 (4), p.321-331

2000

Volltextzugriff (PDF)

RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer's Disease

The Journal of neuroscience, 1999-03, Vol.19 (6), p.1959-1964

1999

Volltextzugriff (PDF)

Higher Incidence of Mild Cognitive Impairment in Familial Hypercholesterolemia

The American journal of medicine, 2010-03, Vol.123 (3), p.267-274

2010

Volltextzugriff (PDF)

Neuronal Oxidative Stress Precedes Amyloid-β Deposition in Down Syndrome

Journal of neuropathology and experimental neurology, 2000-11, Vol.59 (11), p.1011-1017

2000

Volltextzugriff (PDF)

Potent Neuroprotective Properties against the Alzheimer β-Amyloid by an Endogenous Melatonin-related Indole Structure, Indole-3-propionic Acid

The Journal of biological chemistry, 1999-07, Vol.274 (31), p.21937-21942

1999

Volltextzugriff (PDF)

Statin therapy for Alzheimer's disease: will it work?

Journal of molecular neuroscience, 2002-08, Vol.19 (1-2), p.155-161

2002

Volltextzugriff (PDF)

Alzheimer β protein mediated oxidative damage of mitochondrial DNA: Prevention by melatonin

Journal of pineal research, 1999-11, Vol.27 (4), p.226-229

1999

Volltextzugriff (PDF)

Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide

The Journal of neuroscience, 1997-03, Vol.17 (5), p.1683-1690

1997

Volltextzugriff (PDF)

Indole-3-propionate: a potent hydroxyl radical scavenger in rat brain

Brain research, 1999-01, Vol.815 (2), p.382-388

1999

Volltextzugriff (PDF)

Development of indole-3-propionic acid (OXIGON) for Alzheimer's disease

Journal of molecular neuroscience, 2002-08, Vol.19 (1-2), p.213-217

2002

Volltextzugriff (PDF)

Immunohistochemical evidence of antioxidant stress in Alzheimer's disease

The American journal of pathology, 1992-03, Vol.140 (3), p.621-628

1992

Volltextzugriff (PDF)

The Amyloid β Protein Induces Oxidative Damage of Mitochondrial DNA

Journal of neuropathology and experimental neurology, 1997-12, Vol.56 (12), p.1356-1362

1997

Volltextzugriff (PDF)

A unique case of limb-girdle muscular dystrophy type 2A carrying novel compound heterozygous mutations in the human CAPN3 gene

European journal of neurology, 2007-07, Vol.14 (7), p.819-822

2007

Volltextzugriff (PDF)

Increased Expression but Reduced Activity of Antioxidant Enzymes in Alzheimer's Disease

Journal of Alzheimer's disease, 1999-10, Vol.1 (3), p.139-145

1999

Volltextzugriff (PDF)

Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells

Journal of neuroscience research, 1992-10, Vol.33 (2), p.319-329

1992

Volltextzugriff (PDF)

Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging

Magnetic resonance in medicine, 2003-08, Vol.50 (2), p.293-302

2003

Volltextzugriff (PDF)

Amyloid Deposition in Diffuse Plaques May Or May Not Start at the Neuronal Cell Surface Membrane

Journal of neuropathology and experimental neurology, 2001-01, Vol.60 (1), p.105-105

PAPPOLLA, M A

2001

Volltextzugriff (PDF)

Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer’s disease brain

Free radical biology & medicine, 2001-08, Vol.31 (3), p.315-320

2001

Volltextzugriff (PDF)

Prophylactic Actions of Melatonin in Oxidative Neurotoxicity

Annals of the New York Academy of Sciences, 1997-10, Vol.825 (1), p.70-78

1997

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Englisch
(142)
Spanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin : implications for Alzheimer's disease

Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo

Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model

RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer's Disease

Higher Incidence of Mild Cognitive Impairment in Familial Hypercholesterolemia

Neuronal Oxidative Stress Precedes Amyloid-β Deposition in Down Syndrome

Potent Neuroprotective Properties against the Alzheimer β-Amyloid by an Endogenous Melatonin-related Indole Structure, Indole-3-propionic Acid

Statin therapy for Alzheimer's disease: will it work?

Alzheimer β protein mediated oxidative damage of mitochondrial DNA: Prevention by melatonin

Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide

Indole-3-propionate: a potent hydroxyl radical scavenger in rat brain

Development of indole-3-propionic acid (OXIGON) for Alzheimer's disease

Immunohistochemical evidence of antioxidant stress in Alzheimer's disease

The Amyloid β Protein Induces Oxidative Damage of Mitochondrial DNA

A unique case of limb-girdle muscular dystrophy type 2A carrying novel compound heterozygous mutations in the human CAPN3 gene

Increased Expression but Reduced Activity of Antioxidant Enzymes in Alzheimer's Disease

Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells

Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging

Amyloid Deposition in Diffuse Plaques May Or May Not Start at the Neuronal Cell Surface Membrane

Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer’s disease brain

Prophylactic Actions of Melatonin in Oxidative Neurotoxicity

Suchergebnisse filtern